Persistence and Econ”Mic Impact of Etanercept and Adalimumab Dose Reduction In Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Patients With At Least 1 Year In Clinical Remission- Experience From 2 Spanish Teaching Ho ...
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2299
https://www.valueinhealthjournal.com/article/S1098-3015(15)04375-2/fulltext
Title :
Persistence and Econ”Mic Impact of Etanercept and Adalimumab Dose Reduction In Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Patients With At Least 1 Year In Clinical Remission- Experience From 2 Spanish Teaching Ho ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04375-2&doi=10.1016/j.jval.2015.09.2299
First page :
A643
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1710